Fig. 2From: The tRNA-derived fragment 5026a inhibits the proliferation of gastric cancer cells by regulating the PTEN/PI3K/AKT signaling pathwaytRF-5026a may be a potential diagnostic biomarker. a Diagnostic value analysis of tRF-5026a in gastric cancer. b Combined diagnostic assessment of tRF-5026a and tiRNA-5034-GluTTC-2 in tissues and plasma samples. c Prognostic significance of tRF-5026a in gastric cancer patients. Kaplan-Meier analysis of overall survival (OS) based on tRF-5026a expression levels in tissuesBack to article page